Skip to content

About US
About LB-102
Pipeline
Publications
Investors
Careers
Contact Us

Events

Upcoming Events

March 17, 2026

Stifel 2026 Virtual CNS Forum

View Webcast

Past Events

March 11, 2026

Leerink 2026 Global Healthcare Conference

View Webcast

May 27, 2025 - May 30, 2025

American Society of Clinical Psychopharmacology 2025 Annual Meeting

March 29, 2025 - April 2, 2025

2025 Annual Congress of the Schizophrenia International Research Society (SIRS)

IR Contact

Email Alerts Sign-Up

Email

Unsubscribe

Loading...

About US
About LB-102
Pipeline
Publications
Investors
Careers
Contact Us

About US
About LB-102
Pipeline
Publications
Investors
Careers
Contact Us

All Rights Reserved.

About Us
Management
Board of Directors
Scientific Advisory Board
Careers
Contact Us

About LB-102
Pipeline
About Schizophrenia
Publications

Investors Overview
News
Events
Corporate Governance
SEC Filings
Stock Information
Analyst Coverage
Investor FAQs

© 2026 LB Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.

Scroll to Top